Supriya Lifescience Ltd.
SUPRIYA Share PricePharmaceuticals & Drugs
₹745.3
-3.2 (-0.4%)
As on December 4, 2025
Exchange Scrips: BSE543434NSESUPRIYAISININE07RO01027
Market Cap ₹ 6,000 Cr
P/E Ratio 31.91
Dividend Yield 0.07 %
Performance
Market performance
Open744.95
High751.35
Volumes68,336
Prev745.3
Low741.6
As on2025-12-04
Historical performance
1 Year High842
3 Year High842
5 Year High842
1 Year Low556.15
3 Year Low170.15
5 Year Low170.15
Fundamentals
Company Valuation
Market Cap (₹Cr)
6,000
Face Value (₹)
2
P/E Ratio
31.91
Dividend Yield
0.07 %
Investment Returns
1 Year
-7.4%
3 Years
196.2%
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 746.85 | Bearish |
| 10-DMA | 750.89 | Bearish |
| 20-DMA | 763.24 | Bearish |
| 50-DMA | 748.75 | Bearish |
| 100-DMA | 711.42 | Bullish |
| 200-DMA | 698.64 | Bullish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 6 | 6 | 6 | 6 | 6 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 6 | 6 | 6 | 6 | 6 |
| Public Investors | 87906 | 91922 | 91045 | 89388 | 85322 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 31.91.
- 3Y Stock Price CAGR of the stock is 44.3.
- The stock has a beta of 1.7.
- In the last financial year, the company had an EBITDA of ₹2708 Million.
- The company generated revenue of ₹6965 Million in the previous financial year.
Supriya Lifescience Ltd.
745.3-3.2 (-0.4%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 958893.5
No. of Shares: 1287 (Approx)
Performance:-4.1%
P/L: ₹-41106.5
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
